Attribute,Pretty Name,ACC
Days from randomization to diagnosis of lung cancer,Diagnosing,0.8784629745284553
Days from randomization to diagnosis of lung cancer,Carcinoma Of The Lung,0.99
Clinical M for staging,Distantly,0.3131477702399897
Clinical M for staging,Secondary Malignancies,0.99
Clinical M for staging,Unclassified Tumour Malignant,0.99
Clinical M for staging,Distantly,0.3585155692687921
Clinical M for staging,Metastasis From Malignant Neoplasm,0.908818869083051
Clinical M for staging,Presentations,0.7704798873616743
Clinical M for staging,Unclassified Tumour Malignant,0.9797809825500228
Clinical M for staging,Metastasis Present In Distant Organ,1.0
Clinical M for staging,Distant Metastasis Cannot Be Assessed Finding,1.0
Clinical M for staging,Informations,0.341380539753926
AJCC 7th edition staging clinical M component,Distantly,0.3543893837337026
AJCC 7th edition staging clinical M component,Secondary Malignancies,0.99
AJCC 7th edition staging clinical M component,Malignant Neoplastic Disease,0.99
AJCC 7th edition staging clinical M component,Distantly,0.395324403765892
AJCC 7th edition staging clinical M component,Metastasis From Malignant Neoplasm,0.99
AJCC 7th edition staging clinical M component,Presentations,0.7957410417114599
AJCC 7th edition staging clinical M component,Unclassified Tumour Malignant,0.99
AJCC 7th edition staging clinical M component,Metastasis Present In Distant Organ,1.0
AJCC 7th edition staging clinical M component,Secondary Malignancies,0.99
AJCC 7th edition staging clinical M component,Pleural Nodule,1.0
AJCC 7th edition staging clinical M component,Distantly,0.5704934680021289
AJCC 7th edition staging clinical M component,Secondary Malignancies,0.860326831675338
AJCC 7th edition staging clinical M component,Organs Anatomy,0.3418686231216044
AJCC 7th edition staging clinical M component,Thoracic Structure,0.7855247243480978
AJCC 7th edition staging clinical M component,Distant Metastasis Cannot Be Assessed Finding,1.0
Clinical N for staging,Pn1 Regional Lymph Node Stage Finding,1.0
Clinical N for staging,Unclassified Tumour Malignant,0.99
Clinical N for staging,Near To,1.0
Clinical N for staging,Reticuloendothelial System Lymph Node,0.7268041959822873
Clinical N for staging,Secondary Malignancies,0.9022451512042132
Clinical N for staging,Near To,1.0
Clinical N for staging,Reticuloendothelial System Lymph Node,0.721781388815507
Clinical N for staging,Tumour Tissue Sample,0.7960783750804097
Clinical N for staging,Secondary Malignancies,0.9728356155030868
Clinical N for staging,Set Of Regional Lymph Nodes,1.0
Clinical N for staging,Distal Qualifier Value,0.4125352673268351
Clinical N for staging,Tumour Tissue Sample,0.7975234139250745
Clinical N for staging,Anatomic Node,0.99
Clinical N for staging,Secondary Malignancies,0.772921194202503
Clinical N for staging,Reticuloendothelial System Lymph Node,0.7903173331779138
Clinical N for staging,Nodus Lymphaticus Supraclavicularis Axillae,0.5667645333354849
Clinical N for staging,Bone Structure Of Clavicle,1.0
Clinical N for staging,Set Of Regional Lymph Nodes,1.0
Clinical N for staging,Informations,0.5582183352479919
Clinical Stage,Carcinoma Of The Lung,0.8993955922029292
Clinical Stage,Iiia Virus,1.0
Clinical Stage,Stage Iiib Testicular Cancer Ajcc V6 And V7,1.0
Clinical T for staging,Tumour Tissue Sample,0.8340543927794342
Clinical T for staging,Greatest,1.0
Clinical T for staging,Origin Of Organ,1.0
Clinical T for staging,Tumour Tissue Sample,0.7578446662056024
Clinical T for staging,Less Than Or Equal To,1.0
Clinical T for staging,Near To,1.0
Clinical T for staging,Structures,0.396652693961537
Clinical T for staging,Organs Anatomy,0.4104036527307168
Clinical T for staging,Tumour Tissue Sample,0.7815523382747767
Clinical T for staging,Direct Qualifier,1.0
Clinical T for staging,Near To,1.0
Clinical T for staging,Structures,0.4448140925303104
Clinical T for staging,Pleural Membrane Structure,0.5605181611522667
Clinical T for staging,Chest Wall Structure,0.99
Clinical T for staging,Tumour Tissue Sample,0.8708171648489667
Clinical T for staging,Near To,1.0
Clinical T for staging,Structures,0.488930964150561
Clinical T for staging,Organs Anatomy,0.3615149819041838
Clinical T for staging,Respiratory Diaphragms,0.5781700606348459
Clinical T for staging,Tumour Tissue Sample,0.7579397661748181
Clinical T for staging,Tumour Tissue Sample,0.7935641865129934
AJCC 7th edition staging clinical T component,Tumour Tissue Sample,0.9260745622194616
AJCC 7th edition staging clinical T component,Greatest,1.0
AJCC 7th edition staging clinical T component,Tumour Tissue Sample,0.8524688501796116
AJCC 7th edition staging clinical T component,Greatest,1.0
AJCC 7th edition staging clinical T component,Tumour Tissue Sample,0.7993632288612813
AJCC 7th edition staging clinical T component,Less Than Or Equal To,1.0
AJCC 7th edition staging clinical T component,Near To,1.0
AJCC 7th edition staging clinical T component,Structures,0.3799758762687901
AJCC 7th edition staging clinical T component,Organs Anatomy,0.3937340507987825
AJCC 7th edition staging clinical T component,Tumour Tissue Sample,0.782800372518512
AJCC 7th edition staging clinical T component,Tumour Tissue Sample,0.8383258525463413
AJCC 7th edition staging clinical T component,Tumour Tissue Sample,0.849463305114027
AJCC 7th edition staging clinical T component,Direct Qualifier,1.0
AJCC 7th edition staging clinical T component,Near To,1.0
AJCC 7th edition staging clinical T component,Structures,0.4369461512360651
AJCC 7th edition staging clinical T component,Pleural Membrane Structure,0.5628443670700687
AJCC 7th edition staging clinical T component,Chest Wall Structure,0.99
AJCC 7th edition staging clinical T component,Tumour Tissue Sample,0.8708171648489667
AJCC 7th edition staging clinical T component,Near To,1.0
AJCC 7th edition staging clinical T component,Structures,0.4866895759559234
AJCC 7th edition staging clinical T component,Organs Anatomy,0.3488740857447587
AJCC 7th edition staging clinical T component,Respiratory Diaphragms,0.4810159491702945
AJCC 7th edition staging clinical T component,Tumour Tissue Sample,0.4603001457276784
Lung Cancer Grade,Cancer Grade,1.0
Lung Cancer Grade,Cancer Grade,1.0
Lung Cancer Grade,Third Grade In Elementary School,1.0
Lung Cancer Grade,G1 : Well Differentiated Histologic Grade Qualifier Value,1.0
Lung Cancer Grade,G3 : Poorly Differentiated Histologic Grade Qualifier Value,1.0
Lung Cancer Grade,G4 : Undifferentiated Histologic Grade Qualifier Value,1.0
Lung Cancer Grade,Histopathology Report,1.0
"Stage (""Best"": Path if avail., else Clin)",Diagnostic Neoplasm Staging,1.0
"Stage (""Best"": Path if avail., else Clin)",Pathologic Staging,1.0
"Stage (""Best"": Path if avail., else Clin)",Informations,0.3585859020010136
"Stage (""Best"": Path if avail., else Clin)",Iiia Virus,1.0
"Stage (""Best"": Path if avail., else Clin)",Stage Iiib Testicular Cancer Ajcc V6 And V7,1.0
AJCC 7th edition stage,Carcinoma Of The Lung,0.8850490192925646
AJCC 7th edition stage,Iiia Virus,1.0
AJCC 7th edition stage,Stage Iiib Testicular Cancer Ajcc V6 And V7,1.0
ICD-O-3 Morphology (from histology),Morphological,0.5041068959153641
ICD-O-3 Morphology (from histology),Carcinoma Of The Lung,0.8149807450943678
ICD-O-3 Morphology (from histology),Morphological,0.4239198592178861
ICD-O-3 Morphology (from histology),Coding Icd,1.0
ICD-O-3 Morphology (from histology),Representation Action,1.0
ICD-O-3 Morphology (from histology),Informations,0.7451962148519069
ICD-O-3 Morphology (from histology),Type Attribute,0.4093874104677406
ICD-O-3 Morphology (from histology),Unclassified Tumour Malignant,0.7722897566797018
Is this cancer the first lung cancer diagnosed?,Unclassified Tumour Malignant,0.99
Is this cancer the first lung cancer diagnosed?,Carcinoma Of The Lung,0.99
Is this cancer the first lung cancer diagnosed?,Diagnosing,1.0
Is this cancer the first lung cancer diagnosed?,Unclassified Tumour Malignant,0.99
Is this cancer the first lung cancer diagnosed?,Carcinoma Of The Lung,0.99
Is this cancer the first lung cancer diagnosed?,Diagnosing,1.0
Is this cancer the first lung cancer diagnosed?,Malignant Neoplasm Of Lung Multiple Primary Sites,1.0
Is this cancer the first lung cancer diagnosed?,Including Qualifier,1.0
Is this cancer the first lung cancer diagnosed?,Unclassified Tumour Malignant,0.99
ICD-O-3 Behavior,Behavioural Response To Stimulus,0.6474888279497109
ICD-O-3 Behavior,Behavioural Response To Stimulus,0.5619070645650183
ICD-O-3 Behavior,Carcinoma Of The Lung,0.8590117258610416
ICD-O-3 Behavior,Unclassified Tumour Malignant,0.5630279080319347
ICD-O-3 Behavior,Metastasis From Malignant Neoplasm,0.8360410061331832
ICD-O-3 Grade,Third Grade In Elementary School,1.0
ICD-O-3 Grade,Third Grade In Elementary School,1.0
ICD-O-3 Grade,Carcinoma Of The Lung,0.6714203885601948
ICD-O-3 Grade,Well Differentiated,0.3525683942259962
ICD-O-3 Grade,Well Differentiated,0.3034620359019658
ICD-O-3 Morphology,Morphological,0.4835569614182901
ICD-O-3 Morphology,Morphological,0.5948627749458331
ICD-O-3 Morphology,Carcinoma Of The Lung,0.8683441515002088
Order of this lung cancer among all lung cancers for this participant,Carcinoma Of The Lung,0.9585104922852778
Order of this lung cancer among all lung cancers for this participant,Carcinoma Of The Lung,0.9087722722581296
Order of this lung cancer among all lung cancers for this participant,Carcinoma Of The Lung,0.9330572050859236
Order of this lung cancer among all lung cancers for this participant,Carcinoma Of The Lung,0.9064130536266172
ICD-O-3 Topography,Carcinoma Of The Lung,0.99
ICD-O-3 Topography,Genus Salvelinus,1.0
Tumor size (mm) - Pathology,Tumour Tissue Sample,0.9142862672701904
Tumor size (mm) - Pathology,Pathology Field,0.6932644591429891
Pathologic Stage,Pathologic Staging,1.0
Pathologic Stage,Pathologic Staging,1.0
Pathologic Stage,Carcinoma Of The Lung,0.9492073266001468
Pathologic Stage,Iiia Virus,1.0
Pathologic Stage,Stage Iiib Testicular Cancer Ajcc V6 And V7,1.0
"Source of ""best"" stage (de_stag)",Sources,0.4202973451584753
"Source of ""best"" stage (de_stag)",Phased,0.3323573712350458
"Source of ""best"" stage (de_stag)",Indication Of Contextual Qualifier,1.0
"Source of ""best"" stage (de_stag)",Pathology Field,0.6973450075027496
"Stage Only (if separate T, N, & M not available)",Providing Action,0.6194365154827199
"Stage Only (if separate T, N, & M not available)",Phased,0.3138202251861542
"Stage Only (if separate T, N, & M not available)",Informations,0.7030087032989875
"Stage Only (if separate T, N, & M not available)",Carcinoma Of The Lung,0.6710869709011917
"Stage Only (if separate T, N, & M not available)",Carcinoma Of The Lung,0.6491603626426561
"Stage Only (if separate T, N, & M not available)",Pathologic Staging,1.0
"Stage Only (if separate T, N, & M not available)",Tumour Tissue Sample,0.99
"Stage Only (if separate T, N, & M not available)",Lymphomatous Nodal Involvement,0.99
"Stage Only (if separate T, N, & M not available)",Negative For Metastasis,0.4003725504370913
"Stage Only (if separate T, N, & M not available)",Tumour Tissue Sample,0.982820353103858
"Stage Only (if separate T, N, & M not available)",Lymphomatous Nodal Involvement,0.99
"Stage Only (if separate T, N, & M not available)",Negative For Metastasis,0.3980413277836264
"Stage Only (if separate T, N, & M not available)",Tumour Tissue Sample,0.9637100760440522
"Stage Only (if separate T, N, & M not available)",Lymphomatous Nodal Involvement,0.99
"Stage Only (if separate T, N, & M not available)",Negative For Metastasis,0.4488924077335744
"Stage Only (if separate T, N, & M not available)",Tumour Tissue Sample,0.99
"Stage Only (if separate T, N, & M not available)",Localised Disease,0.3952474900655667
"Stage Only (if separate T, N, & M not available)",Lymphomatous Nodal Involvement,0.99
"Stage Only (if separate T, N, & M not available)",Negative For Metastasis,0.4580366621890858
"Stage Only (if separate T, N, & M not available)",Tumour Tissue Sample,0.99
"Stage Only (if separate T, N, & M not available)",Reticuloendothelial System Lymph Node,0.7496522099792159
"Stage Only (if separate T, N, & M not available)",Negative For Metastasis,0.4496013370181755
"Stage Only (if separate T, N, & M not available)",Tumour Tissue Sample,0.99
"Stage Only (if separate T, N, & M not available)",Near To,1.0
"Stage Only (if separate T, N, & M not available)",Organs Anatomy,0.3506170165730851
"Stage Only (if separate T, N, & M not available)",Lymphomatous Nodal Involvement,0.99
"Stage Only (if separate T, N, & M not available)",Negative For Metastasis,0.4407883507117173
"Stage Only (if separate T, N, & M not available)",Tumour Tissue Sample,0.9632984028233826
"Stage Only (if separate T, N, & M not available)",Lymphomatous Nodal Involvement,0.99
"Stage Only (if separate T, N, & M not available)",Distantly,0.3969488594125092
"Stage Only (if separate T, N, & M not available)",Secondary Malignancies,0.8540888663263427
"Stage Only (if separate T, N, & M not available)",Tumour Tissue Sample,0.8327317828551701
Summary staging,Carcinoma Of The Lung,0.7874903274780156
Summary staging,Carcinoma Of The Lung,0.6995867540470599
Summary staging,Pathologic Staging,1.0
Study Year of Diagnosis,Diagnosing,0.7663785264725171
Study Year of Diagnosis,Diagnosing,1.0
Study Year of Diagnosis,One Year,1.0
Study Year of Diagnosis,Diagnosing,0.7708657502759899
Study Year of Diagnosis,Diagnosing,0.734874201294432
Study Year of Diagnosis,Diagnosing,0.7466541291894955
Study Year of Diagnosis,Diagnosing,0.7479573845400339
Study Year of Diagnosis,Diagnosing,0.7452233575625287
Study Year of Diagnosis,Diagnosing,0.6999710448041914
Source of samples for ICD-O-3 code,Sources,0.4231786012498369
Source of samples for ICD-O-3 code,Icd O 3 Code,1.0
Source of samples for ICD-O-3 code,Sources,0.3365786842583984
Source of samples for ICD-O-3 code,Informations,0.6275649978879084
Source of samples for ICD-O-3 code,Icd O 3 Code,1.0
VALCSG Stage (Small cell only),Phased,0.3692197694375206
VALCSG Stage (Small cell only),Cellular Structures,0.9258422352144844
VALCSG Stage (Small cell only),Cellular Structures,0.8955125014988491
VALCSG Stage (Small cell only),Carcinoma Of The Lung,0.99
VALCSG Stage (Small cell only),Carcinoma Of The Lung,0.9125403108743204
VALCSG Stage (Small cell only),Small Cell Neuroendocrine Carcinoma,1.0
VALCSG Stage (Small cell only),Limited Extensiveness,0.5433420238568689
Abnormality description,Abnormalities,0.3743838048042476
Abnormality description,Abnormalities,0.3729499639064024
Abnormality description,Screening Trials,0.3152221011990399
Abnormality description,Numbering System,1.0
Abnormality description,Calcified Qualifier,0.9605547920026772
Abnormality description,Mass Of Body Structure,0.7764517420175594
Abnormality description,Increased Mass To Volume Ratio,0.99
Abnormality description,4 Mm,1.0
Abnormality description,Diameter Qualifier Value,0.414740372887299
Abnormality description,Calcified Qualifier,0.9358237785240916
Abnormality description,Increased Mass To Volume Ratio,0.99
Abnormality description,4 Mm,1.0
Abnormality description,Diameter Qualifier Value,0.3629517545428999
Abnormality description,Small Mass Of The Lung,1.0
Abnormality description,Calcium Buildup In Soft Tissues Of Body,0.99
Abnormality description,Pulmonary Collapse With Atelectasis,0.99
Abnormality description,Thickening Of Pleura,1.0
Abnormality description,Free Fluid,0.99
Abnormality description,Calcified Qualifier,0.99
Abnormality description,Adenopathy Mediastinal,1.0
Abnormality description,Mass Of Body Structure,0.7452250464786251
Abnormality description,Shortest,0.99
Abnormality description,Chest Wall Structure,0.8611425224512443
Abnormality description,Destruction Action,0.820369000752059
Abnormality description,Secondary Malignancies,0.7072467854956572
Abnormality description,Etc .,1.0
Abnormality description,Pulmonary Consolidation,0.99
Abnormality description,Structure Of Cardiovascular System,0.4333389438487777
Abnormality description,Increased Mass To Volume Ratio,0.99
Abnormality description,Fibrous Tissue Formation,0.8446488898839322
Abnormality description,Unclassified Tumour Malignant,0.9464905412439087
Abnormality description,Increased Mass To Volume Ratio,0.99
Abnormality description,4 Mm,1.0
Abnormality description,Respiratory Diaphragms,0.5610083719436385
Abnormality description,Respiratory Diaphragms,0.5159989836776169
Abnormality description,Minor Disease,0.5271660615111456
Abnormality description,Abnormalities,0.3382470305902458
Abnormality description,Notable,1.0
Abnormality number (unique identifier),Unique,1.0
Abnormality number (unique identifier),Number Assigned,1.0
Abnormality number (unique identifier),Solute Carrier Family 33 Member 1,1.0
Abnormality number (unique identifier),Scientific Studies,0.3367136760168778
Abnormality number (unique identifier),Abnormalities,0.3113474875625399
Abnormality number (unique identifier),Scientific Studies,0.394216286658523
Abnormality number (unique identifier),Pid Pelvic Inflammatory Disease,0.3344057497749573
Abnormality number (unique identifier),Scientific Studies,0.3919477569451842
Abnormality number (unique identifier),Abnormalities,0.3441666500370011
Abnormality number (unique identifier),Tomography Spiral Computer Assisted,0.5081611920278318
Abnormality number (unique identifier),Abnormalities,1.0
Location of epicenter,Calcified Qualifier,0.8061008954403134
Location of epicenter,4 Mm,1.0
Location of epicenter,Diameter Qualifier Value,0.4250547741950125
Location of epicenter,No Apparent Adverse Event,0.4293132453261472
Location of epicenter,Structure Of Right Upper Lobe Of Lung,0.8111675400799981
Location of epicenter,Structure Of Right Middle Lobe Of Lung,0.9337394737526552
Location of epicenter,Structure Of Lower Lobe Of Right Lung,0.840304359575649
Location of epicenter,Structure Of Upper Lobe Of Left Lung,0.8886446409963985
Location of epicenter,Structure Of Lingula Of Left Lung,0.99
Location of epicenter,Structure Of Lower Lobe Of Left Lung,0.8482504661471137
Location of epicenter,Other : Specify,1.0
Was the abnormality not identified until the comparison with historical images?,Regardless,1.0
Was the abnormality not identified until the comparison with historical images?,Of Presence,1.0
Was the abnormality not identified until the comparison with historical images?,Screens Device,0.3808013783786071
Was the abnormality not identified until the comparison with historical images?,Of Presence,1.0
Longest diameter (in mm),Longest Measurement,0.7633362761984956
Longest diameter (in mm),Longest Measurement,0.7579408889183108
Longest diameter (in mm),Calcified Qualifier,0.7270457779024175
Longest diameter (in mm),4 Mm,1.0
Longest diameter (in mm),Diameter Qualifier Value,0.4262375266101726
Longest diameter (in mm),No Apparent Adverse Event,0.6623774240544793
Longest diameter (in mm),Could Not Be Determined,1.0
Margins,Margins Of Excision,0.530685621773644
Margins,Margins Of Excision,0.5441112155557299
Margins,Calcified Qualifier,0.5782105033804535
Margins,4 Mm,1.0
Margins,Diameter Qualifier Value,0.3596231404646995
Margins,No Apparent Adverse Event,0.5882061917347845
Margins,Micro Spiculations,1.0
Margins,Could Not Be Determined,1.0
Longest perpendicular diameter (same CT slice in mm),Longest Perpendicular,0.6374559806195366
Longest perpendicular diameter (same CT slice in mm),Diameter Qualifier Value,0.3827798215473594
Longest perpendicular diameter (same CT slice in mm),Slice,1.0
Longest perpendicular diameter (same CT slice in mm),Longest Measurement,0.7452995130712724
Longest perpendicular diameter (same CT slice in mm),Diameter Qualifier Value,0.3768670156297852
Longest perpendicular diameter (same CT slice in mm),Calcified Qualifier,0.7469848332476192
Longest perpendicular diameter (same CT slice in mm),4 Mm,1.0
Longest perpendicular diameter (same CT slice in mm),Diameter Qualifier Value,0.4246322165570156
Longest perpendicular diameter (same CT slice in mm),No Apparent Adverse Event,0.6583223216946767
Longest perpendicular diameter (same CT slice in mm),Could Not Be Determined,1.0
Predominant attenuation,Predominant,1.0
Predominant attenuation,Attenuation,0.5004648233716243
Predominant attenuation,Predominant,1.0
Predominant attenuation,Attenuation,0.5007233843697872
Predominant attenuation,Calcified Qualifier,0.8564754579999011
Predominant attenuation,4 Mm,1.0
Predominant attenuation,Diameter Qualifier Value,0.418629865288754
Predominant attenuation,No Apparent Adverse Event,0.6486730682464235
Predominant attenuation,Softly,0.5181656402652038
Predominant attenuation,Tissue Specimen,0.6776330266297691
Predominant attenuation,Ground Glass,1.0
Predominant attenuation,Body Fluids Substance,0.3717727541602247
Predominant attenuation,Unilocular Adipose Tissue,0.4971888314592062
Predominant attenuation,Could Not Be Determined,1.0
CT slice number containing abnormality's greatest diameter,Slice,1.0
CT slice number containing abnormality's greatest diameter,Count Of Entities,0.3627454461657397
CT slice number containing abnormality's greatest diameter,Contain Action,0.7907450115019338
CT slice number containing abnormality's greatest diameter,Longest Measurement,1.0
CT slice number containing abnormality's greatest diameter,Slice,1.0
CT slice number containing abnormality's greatest diameter,Count Of Entities,0.3500181690398061
CT slice number containing abnormality's greatest diameter,Contain Action,0.8278714151604627
CT slice number containing abnormality's greatest diameter,Longest Measurement,1.0
CT slice number containing abnormality's greatest diameter,Calcified Qualifier,0.7910668751701821
CT slice number containing abnormality's greatest diameter,4 Mm,1.0
CT slice number containing abnormality's greatest diameter,Diameter Qualifier Value,0.433472742752223
CT slice number containing abnormality's greatest diameter,No Apparent Adverse Event,0.66012580716673
Study year of screen,Scientific Studies,0.4417249657717108
Study year of screen,Screens Device,0.545533875882022
Study year of screen,Screening Trials,0.4439825938097859
Study year of screen,Active Follow Up,0.6648857907948227
Study year of screen,Screening Trials,0.360901899809067
Interval suspicious change in attenuation,Attenuation,0.4098372662603657
Interval suspicious change in attenuation,Attenuation,0.4633038722404852
Interval suspicious change in attenuation,Calcified Qualifier,0.8831487482586304
Interval suspicious change in attenuation,4 Mm,1.0
Interval suspicious change in attenuation,Diameter Qualifier Value,0.4445266957247369
Interval suspicious change in attenuation,No Apparent Adverse Event,0.368413061682362
Interval suspicious change in attenuation,Attenuation,0.4577505307976315
Interval suspicious change in attenuation,Calcified Qualifier,0.9123489175066825
Interval suspicious change in attenuation,4 Mm,1.0
Interval suspicious change in attenuation,Diameter Qualifier Value,0.4258529052865611
Interval suspicious change in attenuation,Attenuation,0.4764967021655307
Interval suspicious change in attenuation,Calcified Qualifier,0.9240821682054084
Interval suspicious change in attenuation,4 Mm,1.0
Interval suspicious change in attenuation,Diameter Qualifier Value,0.3890001701457606
Interval suspicious change in attenuation,Could Not Be Determined,1.0
Interval suspicious change in attenuation,Attenuation,0.4753524946190215
Interval suspicious change in attenuation,Calcified Qualifier,0.9091850245720732
Interval suspicious change in attenuation,4 Mm,1.0
Interval suspicious change in attenuation,Diameter Qualifier Value,0.4524719098475235
Abnormality code number,Abnormalities,0.3181448332777093
Abnormality code number,Equivalent Unit,1.0
Abnormality code number,Abnormalities,0.3680784722326112
Abnormality code number,Tomography Spiral Computer Assisted,0.3355422453385575
Abnormality code number,Abnormalities,0.4029453443702342
Abnormality code number,Screening Trials,0.3289276184137978
Abnormality code number,Usages,0.3752255409710208
Abnormality code number,Numbering System,1.0
Abnormality code number,Calcified Qualifier,0.9712400460052656
Abnormality code number,Mass Of Body Structure,0.775165735839612
Abnormality code number,Increased Mass To Volume Ratio,0.99
Abnormality code number,4 Mm,1.0
Abnormality code number,Diameter Qualifier Value,0.4137618153035485
Abnormality code number,Calcified Qualifier,0.9352926407442324
Abnormality code number,Increased Mass To Volume Ratio,0.99
Abnormality code number,4 Mm,1.0
Abnormality code number,Diameter Qualifier Value,0.3629517545428999
Abnormality code number,Small Mass Of The Lung,1.0
Abnormality code number,Calcium Buildup In Soft Tissues Of Body,0.99
Abnormality code number,Pulmonary Collapse With Atelectasis,0.99
Abnormality code number,Thickening Of Pleura,1.0
Abnormality code number,Free Fluid,0.99
Abnormality code number,Calcified Qualifier,0.99
Abnormality code number,Adenopathy Mediastinal,1.0
Abnormality code number,Mass Of Body Structure,0.7452250464786251
Abnormality code number,Shortest,0.99
Abnormality code number,Chest Wall Structure,0.8611425224512443
Abnormality code number,Destruction Action,0.820369000752059
Abnormality code number,Secondary Malignancies,0.7072467854956572
Abnormality code number,Etc .,1.0
Abnormality code number,Pulmonary Consolidation,0.99
Abnormality code number,Structure Of Cardiovascular System,0.4333389438487777
Abnormality code number,Increased Mass To Volume Ratio,0.99
Abnormality code number,Fibrous Tissue Formation,0.8446488898839322
Abnormality code number,Unclassified Tumour Malignant,0.9464905412439087
Abnormality code number,Increased Mass To Volume Ratio,0.99
Abnormality code number,4 Mm,1.0
Abnormality code number,Respiratory Diaphragms,0.5610083719436385
Abnormality code number,Respiratory Diaphragms,0.5159989836776169
Abnormality code number,Minor Disease,0.5271660615111456
Abnormality code number,Abnormalities,0.3382470305902458
Abnormality code number,Notable,1.0
Interval growth of abnormality (for code 51 only),Calcified Qualifier,0.7854575089800636
Interval growth of abnormality (for code 51 only),4 Mm,1.0
Interval growth of abnormality (for code 51 only),Diameter Qualifier Value,0.4238172111585648
Interval growth of abnormality (for code 51 only),No Apparent Adverse Event,0.6483433024287031
Interval growth of abnormality (for code 51 only),Could Not Be Determined,1.0
Interval change warrants further investigation (for oth. sig. abn. only),12 Lead Electrocardiogram : Interval Change,1.0
Interval change warrants further investigation (for oth. sig. abn. only),Effectiveness Assessment,0.3578053099109258
Interval change warrants further investigation (for oth. sig. abn. only),12 Lead Electrocardiogram : Interval Change,1.0
Interval change warrants further investigation (for oth. sig. abn. only),Effectiveness Assessment,0.6122438984105527
Interval change warrants further investigation (for oth. sig. abn. only),Calcified Qualifier,0.9022007910069068
Interval change warrants further investigation (for oth. sig. abn. only),4 Mm,1.0
Interval change warrants further investigation (for oth. sig. abn. only),Diameter Qualifier Value,0.4261625222709227
Interval change warrants further investigation (for oth. sig. abn. only),No Apparent Adverse Event,0.9289895248807852
Interval change warrants further investigation (for oth. sig. abn. only),Could Not Be Determined,1.0
Abnormality number (unique identifier),Unique,1.0
Abnormality number (unique identifier),Number Assigned,1.0
Abnormality number (unique identifier),Solute Carrier Family 33 Member 1,1.0
Abnormality number (unique identifier),Scientific Studies,0.3367136760168778
Abnormality number (unique identifier),Abnormalities,0.3105677987953212
Abnormality number (unique identifier),Scientific Studies,0.3791194585273605
Abnormality number (unique identifier),Pid Pelvic Inflammatory Disease,0.3186042101419944
Abnormality number (unique identifier),Scientific Studies,0.3689014713908266
Abnormality number (unique identifier),Predominant,0.8840289689113809
Abnormality number (unique identifier),Tomography Spiral Computer Assisted,0.4591427095477842
Was abnormality pre-existing?,Pre Existing,1.0
Was abnormality pre-existing?,Pre Existing,1.0
Was abnormality pre-existing?,Could Not Be Determined,1.0
Study Year of Screen,Scientific Studies,0.4100286058928173
Study Year of Screen,Screens Device,0.3193177275122584
Days from randomization date to earliest date visible,Date Property,0.643586467154518
Days from randomization date to earliest date visible,Date Property,0.6542978198818739
Days from randomization date to earliest date visible,Date Property,0.6948685025545561
Days from randomization date to earliest date visible,Pre Existing,1.0
Days from randomization date to earliest date visible,No Apparent Adverse Event,0.99
Age at randomization (in years; whole number),Current Chronological Age,0.80775798322872
Age at randomization (in years; whole number),Whole Number,1.0
Gender,Male Individual,0.6381730587691153
Gender,Female Gender Self Reported,0.8930018914138104
Race,Black Coloring,0.6437768380850584
Race,Indigenous People Of Alaska,1.0
Race,Hawaiian Population,1.0
Race,Pacific Islander Americans,1.0
Race,More Than One Race,1.0
Race,Participant Refused,1.0
Race,Missing Data,1.0
Race,Decline To Answer,1.0
Smoking status at T0,Cigarette Smoke Substance,0.569789086866507
Smoking status at T0,Quitting,0.6984681107641155
Smoking status at T0,Determined By,0.4443194355427276
Smoking status at T0,Clinical Trials Unspecified,1.0
Smoking status at T0,Screening Trials,0.3167083770370597
Result of screen associated with the first confirmed lung cancer diagnosis,Screens Device,0.5444165376453017
Result of screen associated with the first confirmed lung cancer diagnosis,Associated With,1.0
Result of screen associated with the first confirmed lung cancer diagnosis,Confirmation,0.5252531517600811
Result of screen associated with the first confirmed lung cancer diagnosis,Cancers Diagnosis,1.0
Result of screen associated with the first confirmed lung cancer diagnosis,Unclassified Tumour Malignant,0.876611168652125
Result of screen associated with the first confirmed lung cancer diagnosis,Positive Lymph Node,0.7252064613961677
Result of screen associated with the first confirmed lung cancer diagnosis,Negative Lymph Node,0.7126752174319132
Result of screen associated with the first confirmed lung cancer diagnosis,Screens Device,0.9314991987696032
Result of screen associated with the first confirmed lung cancer diagnosis,Occur Action,1.0
Result of screen associated with the first confirmed lung cancer diagnosis,Screening Trials,0.4599740646965851
Result of screen associated with the first confirmed lung cancer diagnosis,Unclassified Tumour Malignant,0.5943414144288863
Result of screen associated with the first confirmed lung cancer diagnosis,Positive,0.6420075188512366
Result of screen associated with the first confirmed lung cancer diagnosis,Screens Device,0.99
Result of screen associated with the first confirmed lung cancer diagnosis,For Negative,0.5244498842738952
Result of screen associated with the first confirmed lung cancer diagnosis,Screens Device,0.99
Result of screen associated with the first confirmed lung cancer diagnosis,Screens Device,0.99
Result of screen associated with the first confirmed lung cancer diagnosis,Screening Trials,0.3963892539234945
Days from randomization to date when participant was last known to be free from lung cancer,Date Property,0.6371264474851928
Days from randomization to date when participant was last known to be free from lung cancer,Carcinoma Of The Lung,0.7772638174579078
Days from randomization to date when participant was last known to be free from lung cancer,Date Property,0.7411998621691691
Days from randomization to date when participant was last known to be free from lung cancer,Carcinoma Of The Lung,0.9125662984445272
Days from randomization to date when participant was last known to be free from lung cancer,Date Property,0.9722684706329988
Days from randomization to date when participant was last known to be free from lung cancer,Unclassified Tumour Malignant,0.9635664532167184
Days from randomization to date when participant was last known to be free from lung cancer,Cancers Diagnosis,1.0
Days from randomization to date when participant was last known to be free from lung cancer,Date Property,0.6536690592472973
Days from randomization to date when participant was last known to be free from lung cancer,Do Not Use,1.0
Days from randomization to date when participant was last known to be free from lung cancer,Calculation Technique,1.0
Days from randomization to date when participant was last known to be free from lung cancer,Active Follow Up,0.6621977601792517
Days from randomization to date when participant was last known to be free from lung cancer,Carcinoma Of The Lung,0.629863685822333
Days from randomization to date when participant was last known to be free from lung cancer,Etc .,1.0
Days from randomization to date when participant was last known to be free from lung cancer,Usages,0.6853949164902342
Is the diagnosis of lung cancer associated with a positive screen?,Diagnosing,0.9295725806818648
Is the diagnosis of lung cancer associated with a positive screen?,Carcinoma Of The Lung,0.99
Is the diagnosis of lung cancer associated with a positive screen?,Associated With,1.0
Is the diagnosis of lung cancer associated with a positive screen?,Positive Lymph Node,0.7394150241095523
Is the diagnosis of lung cancer associated with a positive screen?,Screens Device,0.3788338650928291
Is the diagnosis of lung cancer associated with a positive screen?,Diagnosing,0.9201492631778434
Is the diagnosis of lung cancer associated with a positive screen?,Carcinoma Of The Lung,0.9077467336008682
Is the diagnosis of lung cancer associated with a positive screen?,Associated With,1.0
Is the diagnosis of lung cancer associated with a positive screen?,Positive Lymph Node,0.7747310719684195
Is the diagnosis of lung cancer associated with a positive screen?,Screens Device,0.5768923076587641
Is the diagnosis of lung cancer associated with a positive screen?,Positive Lymph Node,0.7412559264432708
Is the diagnosis of lung cancer associated with a positive screen?,Screens Device,0.6917841561226153
Is the diagnosis of lung cancer associated with a positive screen?,Cancers Diagnosis,1.0
Is the diagnosis of lung cancer associated with a positive screen?,Associated With,1.0
Is the diagnosis of lung cancer associated with a positive screen?,Diagnostic Test Procedure,0.4949653504563684
Study year associated with first confirmed lung cancer,Associated With,0.4213492664548093
Study year associated with first confirmed lung cancer,Confirmation,0.5076982137235917
Study year associated with first confirmed lung cancer,Carcinoma Of The Lung,0.99
Study year associated with first confirmed lung cancer,Associated With,0.4055740274197331
Study year associated with first confirmed lung cancer,Confirmation,0.4988830678744302
Study year associated with first confirmed lung cancer,Carcinoma Of The Lung,0.99
Study year associated with first confirmed lung cancer,Unclassified Tumour Malignant,0.99
Study year associated with first confirmed lung cancer,Associated With,0.3326982039460758
Study year associated with first confirmed lung cancer,Positive Lymph Node,0.6547563249906896
Study year associated with first confirmed lung cancer,Screens Device,0.5905881470557234
Study year associated with first confirmed lung cancer,Scientific Studies,0.4203328941020234
Study year associated with first confirmed lung cancer,Screens Device,0.7196169937859277
Study year associated with first confirmed lung cancer,No Apparent Adverse Event,0.99
Days from randomization to first diagnosis of lung cancer,Diagnosing,0.8540910322074842
Days from randomization to first diagnosis of lung cancer,Carcinoma Of The Lung,0.9784314572187792
Days from randomization to first diagnosis of lung cancer,Diagnosing,0.6293761839537317
Days from randomization to first diagnosis of lung cancer,Date Property,0.8108801458582876
Lung cancer grade,Cancer Grade,1.0
Lung cancer grade,No Apparent Adverse Event,0.4873423245308568
Lung cancer grade,Grade Cannot Be Assessed Gx,1.0
Lung cancer grade,G1 : Well Differentiated Histologic Grade Qualifier Value,1.0
Lung cancer grade,G3 : Poorly Differentiated Histologic Grade Qualifier Value,1.0
Lung cancer grade,G4 : Undifferentiated Histologic Grade Qualifier Value,1.0
Lung cancer grade,Histopathology Report,1.0
Lung cancer Stage,Diagnostic Neoplasm Staging,1.0
Lung cancer Stage,Diagnostic Neoplasm Staging,1.0
Lung cancer Stage,Pathologic Staging,1.0
Lung cancer Stage,No Apparent Adverse Event,0.7966493201648468
Lung cancer Stage,Iiia Virus,1.0
Lung cancer Stage,Stage Iiib Testicular Cancer Ajcc V6 And V7,1.0
AJCC 7th edition stage,Carcinoma Of The Lung,0.8874694894304959
AJCC 7th edition stage,No Apparent Adverse Event,0.7291733137063952
AJCC 7th edition stage,Iiia Virus,1.0
AJCC 7th edition stage,Stage Iiib Testicular Cancer Ajcc V6 And V7,1.0
Lung cancer type from ICD-O-3 morphology,Carcinoma Of The Lung,0.9586448324915814
Lung cancer type from ICD-O-3 morphology,Morphological,0.4474322329012949
Lung cancer type from ICD-O-3 morphology,Carcinoma Of The Lung,0.8149585335469156
Lung cancer type from ICD-O-3 morphology,Morphological,0.3811957208660801
Lung cancer type from ICD-O-3 morphology,Coding Icd,1.0
Lung cancer type from ICD-O-3 morphology,Representation Action,1.0
Lung cancer type from ICD-O-3 morphology,Informations,0.7446487561617072
Lung cancer type from ICD-O-3 morphology,Type Attribute,0.4115766959778787
Lung cancer type from ICD-O-3 morphology,Unclassified Tumour Malignant,0.7598480596678823
Lung cancer type from ICD-O-3 morphology,No Apparent Adverse Event,0.99
Pathology lesion size of tumor in millimeters,Pathology Field,0.7103828387580251
Pathology lesion size of tumor in millimeters,Size Of Lesion,1.0
Pathology lesion size of tumor in millimeters,Tumour Tissue Sample,0.99
Pathology lesion size of tumor in millimeters,No Apparent Adverse Event,0.99
Cancer in Carina,Unclassified Tumour Malignant,0.99
Cancer in Carina,Tumour Tissue Sample,0.7443400867924973
Cancer in Carina,Tumour Tissue Sample,0.8378469928848093
Cancer in Carina,More Than One,1.0
Cancer in Carina,No Apparent Adverse Event,0.8932374200244971
Cancer in Left Hilum,Malignant Neoplastic Disease,0.99
Cancer in Left Hilum,Left Hilum,1.0
Cancer in Left Hilum,Tumour Tissue Sample,0.99
Cancer in Left Hilum,Left Hilum,1.0
Cancer in Left Hilum,Tumour Tissue Sample,0.99
Cancer in Left Hilum,More Than One,1.0
Cancer in Left Hilum,No Apparent Adverse Event,0.8818603724916569
Cancer in Lingula,Malignant Neoplastic Disease,0.99
Cancer in Lingula,Structure Of Lingula Of Left Lung,0.5190458390532752
Cancer in Lingula,Tumour Tissue Sample,0.8731531424381074
Cancer in Lingula,Structure Of Lingula Of Left Lung,0.6913122663924198
Cancer in Lingula,Tumour Tissue Sample,0.9431285921215516
Cancer in Lingula,More Than One,1.0
Cancer in Lingula,No Apparent Adverse Event,0.8961755338879991
Cancer in Left lower lobe,Unclassified Tumour Malignant,0.99
Cancer in Left lower lobe,Structure Of Lower Lobe Of Left Lung,0.6884199765106579
Cancer in Left lower lobe,Tumour Tissue Sample,0.9303807077471168
Cancer in Left lower lobe,Structure Of Lower Lobe Of Left Lung,0.726664163666589
Cancer in Left lower lobe,Tumour Tissue Sample,0.99
Cancer in Left lower lobe,More Than One,1.0
Cancer in Left lower lobe,No Apparent Adverse Event,0.872103920543673
Cancer in Left main stem bronchus,Unclassified Tumour Malignant,0.99
Cancer in Left main stem bronchus,Left Main Coronary Artery Segment,1.0
Cancer in Left main stem bronchus,Bronchial Structure,0.931634985643461
Cancer in Left main stem bronchus,Tumour Tissue Sample,0.9261230500556904
Cancer in Left main stem bronchus,Left Main Coronary Artery Segment,1.0
Cancer in Left main stem bronchus,Bronchial Structure,0.9334168029737696
Cancer in Left main stem bronchus,Tumour Tissue Sample,0.980188830058498
Cancer in Left main stem bronchus,More Than One,1.0
Cancer in Left main stem bronchus,No Apparent Adverse Event,0.8744404719929342
Cancer in Left upper lobe,Malignant Neoplastic Disease,0.99
Cancer in Left upper lobe,Structure Of Upper Lobe Of Left Lung,0.7614951268447044
Cancer in Left upper lobe,Tumour Tissue Sample,0.99
Cancer in Left upper lobe,Structure Of Upper Lobe Of Left Lung,0.7970418784153506
Cancer in Left upper lobe,Tumour Tissue Sample,0.99
Cancer in Left upper lobe,More Than One,1.0
Cancer in Left upper lobe,No Apparent Adverse Event,0.8663494796896466
Cancer in Mediastinum,Malignant Neoplastic Disease,0.99
Cancer in Mediastinum,Tumour Tissue Sample,0.8925556650460482
Cancer in Mediastinum,Tumour Tissue Sample,0.960701431701553
Cancer in Mediastinum,More Than One,1.0
Cancer in Mediastinum,No Apparent Adverse Event,0.8904641090937495
Cancer in Other Location,Malignant Neoplastic Disease,0.99
Cancer in Other Location,Other Location,1.0
Cancer in Other Location,Tumour Tissue Sample,0.7258592863376612
Cancer in Other Location,Tumour Tissue Sample,0.7799332642345334
Cancer in Other Location,More Than One,1.0
Cancer in Other Location,No Apparent Adverse Event,0.8942960888674345
Cancer in Right Hilum,Malignant Neoplastic Disease,0.99
Cancer in Right Hilum,Right Hilum,1.0
Cancer in Right Hilum,Tumour Tissue Sample,0.99
Cancer in Right Hilum,Right Hilum,1.0
Cancer in Right Hilum,Tumour Tissue Sample,0.99
Cancer in Right Hilum,More Than One,1.0
Cancer in Right Hilum,No Apparent Adverse Event,0.8829554599570775
Cancer in Right lower lobe,Unclassified Tumour Malignant,0.99
Cancer in Right lower lobe,Structure Of Lower Lobe Of Right Lung,0.6900614328765727
Cancer in Right lower lobe,Tumour Tissue Sample,0.9242149432981912
Cancer in Right lower lobe,Structure Of Lower Lobe Of Right Lung,0.7518125683066889
Cancer in Right lower lobe,Tumour Tissue Sample,0.99
Cancer in Right lower lobe,More Than One,1.0
Cancer in Right lower lobe,No Apparent Adverse Event,0.8729709611241754
Cancer in Right middle lobe,Malignant Neoplastic Disease,0.99
Cancer in Right middle lobe,Structure Of Right Middle Lobe Of Lung,0.7683347511268891
Cancer in Right middle lobe,Tumour Tissue Sample,0.9890892914983956
Cancer in Right middle lobe,Structure Of Right Middle Lobe Of Lung,0.8125795996509317
Cancer in Right middle lobe,Tumour Tissue Sample,0.99
Cancer in Right middle lobe,More Than One,1.0
Cancer in Right middle lobe,No Apparent Adverse Event,0.8725496346601693
Cancer in Right main stem bronchus,Unclassified Tumour Malignant,0.99
Cancer in Right main stem bronchus,Predominant,0.8910520604687071
Cancer in Right main stem bronchus,Bony Appendage,0.3601843884925073
Cancer in Right main stem bronchus,Bronchial Structure,0.9332901867007694
Cancer in Right main stem bronchus,Tumour Tissue Sample,0.9298654984986938
Cancer in Right main stem bronchus,Predominant,0.9426846499018384
Cancer in Right main stem bronchus,Bony Appendage,0.3717308898955838
Cancer in Right main stem bronchus,Bronchial Structure,0.9343102613473891
Cancer in Right main stem bronchus,Tumour Tissue Sample,0.9835139981399192
Cancer in Right main stem bronchus,More Than One,1.0
Cancer in Right main stem bronchus,No Apparent Adverse Event,0.8753141964581644
Cancer in Right upper lobe,Malignant Neoplastic Disease,0.99
Cancer in Right upper lobe,Structure Of Right Upper Lobe Of Lung,0.6534708026971199
Cancer in Right upper lobe,Tumour Tissue Sample,0.99
Cancer in Right upper lobe,Structure Of Right Upper Lobe Of Lung,0.6930644432697837
Cancer in Right upper lobe,Tumour Tissue Sample,0.99
Cancer in Right upper lobe,More Than One,1.0
Cancer in Right upper lobe,No Apparent Adverse Event,0.867243866240387
Cancer in Unknown location,Unclassified Tumour Malignant,0.99
Cancer in Unknown location,Oncological Abnormality,0.647530690758881
Cancer in Unknown location,Tumour Tissue Sample,0.7484667646602696
Cancer in Unknown location,More Than One,1.0
Cancer in Unknown location,No Apparent Adverse Event,0.8964768120625728
Overall diagnostic quality of CT examination,Diagnostic Quality,1.0
Overall diagnostic quality of CT examination,Diagnosing,0.3086944601674355
Reason for limited / non-diagnostic CT: Severe beam hardening artifact,Indication Of Contextual Qualifier,1.0
Reason for limited / non-diagnostic CT: Severe beam hardening artifact,Limited Extensiveness,0.3577222716740704
Reason for limited / non-diagnostic CT: Severe beam hardening artifact,Diagnosing,0.5213874374644225
Reason for limited / non-diagnostic CT: Severe beam hardening artifact,Intensity And Distress 5,0.3905844804194025
Reason for limited / non-diagnostic CT: Severe beam hardening artifact,Beam Hardening Artifact,1.0
Reason for limited / non-diagnostic CT: Severe beam hardening artifact,No Apparent Adverse Event,0.6279806500115698
Reason for limited / non-diagnostic CT: Submaximal inspiratory breath-hold,Indication Of Contextual Qualifier,1.0
Reason for limited / non-diagnostic CT: Submaximal inspiratory breath-hold,Interrupted Respiration,1.0
Reason for limited / non-diagnostic CT: Submaximal inspiratory breath-hold,No Apparent Adverse Event,0.7641750075313014
Reason for limited / non-diagnostic CT: Excessive quantum mottle or graininess,Indication Of Contextual Qualifier,1.0
Reason for limited / non-diagnostic CT: Excessive quantum mottle or graininess,Quantum,1.0
Reason for limited / non-diagnostic CT: Excessive quantum mottle or graininess,No Apparent Adverse Event,0.8554168827118565
Reason for limited / non-diagnostic CT: Lungs not completely imaged,Indication Of Contextual Qualifier,1.0
Reason for limited / non-diagnostic CT: Lungs not completely imaged,Limited Extensiveness,0.3490245733565632
Reason for limited / non-diagnostic CT: Lungs not completely imaged,No Apparent Adverse Event,0.6661370885571591
Reason for limited / non-diagnostic CT: Motion artifact,Indication Of Contextual Qualifier,1.0
Reason for limited / non-diagnostic CT: Motion artifact,Limited Extensiveness,0.533212005137703
Reason for limited / non-diagnostic CT: Motion artifact,No Apparent Adverse Event,0.5492915978636524
Reason for limited / non-diagnostic CT: Other (specify),Indication Of Contextual Qualifier,1.0
Reason for limited / non-diagnostic CT: Other (specify),Diagnosing,0.3421408310952045
Reason for limited / non-diagnostic CT: Other (specify),Other : Specify,1.0
Reason for limited / non-diagnostic CT: Other (specify),No Apparent Adverse Event,0.8700210184042821
Reason for limited / non-diagnostic CT: Respiratory misregistration,Indication Of Contextual Qualifier,1.0
Reason for limited / non-diagnostic CT: Respiratory misregistration,Diagnosing,0.305490315118463
Reason for limited / non-diagnostic CT: Respiratory misregistration,Respiratory System Observation,0.4810105406483075
Reason for limited / non-diagnostic CT: Respiratory misregistration,No Apparent Adverse Event,0.7631158229839243
Reason for limited / non-diagnostic CT: Incorrect technical parameter(s),Indication Of Contextual Qualifier,1.0
Reason for limited / non-diagnostic CT: Incorrect technical parameter(s),Diagnostic Intent,0.3051001818339608
Reason for limited / non-diagnostic CT: Incorrect technical parameter(s),Techniques Values,1.0
Reason for limited / non-diagnostic CT: Incorrect technical parameter(s),No Apparent Adverse Event,0.8557628107440809
Study Year of Screen,Scientific Studies,0.4100286058928173
Study Year of Screen,Screens Device,0.3193177275122584
Technical parameters: Effective mAs,Techniques Values,1.0
Technical parameters: Effective mAs,Techniques Values,1.0
Technical parameters: Effective mAs,Collection Action,0.7674743305713991
Technical parameters: Effective mAs,Obtained,1.0
Technical parameters: Effective mAs,Collection Action,0.99
Technical parameters: Display FOV in cm,Techniques Values,1.0
Technical parameters: Display FOV in cm,Display Arrangement,0.6074565935652502
Technical parameters: Display FOV in cm,Techniques Values,1.0
Technical parameters: Display FOV in cm,Display Arrangement,0.7712835734225225
Technical parameters: Display FOV in cm,Collection Action,0.9108007526485415
Technical parameters: Display FOV in cm,Obtained,1.0
Technical parameters: Display FOV in cm,Collection Action,0.99
Technical parameters: kVp,Techniques Values,1.0
Technical parameters: kVp,Techniques Values,1.0
Technical parameters: kVp,Collection Action,0.7727487936507597
Technical parameters: kVp,Obtained,1.0
Technical parameters: kVp,Collection Action,0.99
Technical parameters: mA,Techniques Values,1.0
Technical parameters: mA,Techniques Values,1.0
Technical parameters: mA,Collection Action,0.7338159238427178
Technical parameters: mA,Obtained,1.0
Technical parameters: mA,Collection Action,0.99
